Skip to main content Accessibility help

Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients

  • Anne Marie Chaftari (a1), Ray Hachem (a1), Ying Jiang (a1), Pankil Shah (a1), Alawami Hussain (a1), Zainab Al Hamal (a1), Ammar Yousif (a1), Mary Jordan (a1), Majd Michael (a1) and Issam Raad (a1)...


We compared the etiologic organisms of bloodstream infections (BSIs) in cancer patients with central venous catheters (CVCs) between 2 cohorts separated by more than a decade.

Gram-negative organisms have become the predominant etiologic organisms of BSIs (52%); they now contribute to 41% of catheter-related BSIs (CRBSIs).

Infect Control Hosp Epidemiol 2018;39:727–729


Corresponding author

Address correspondence to Anne Marie Chaftari, MD, Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (


Hide All
1. Raad, I, Chaftari, AM. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clin Infect Dis 2014;59(Suppl 5):S340S343.
2. Mermel, LA, Allon, M, Bouza, E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:145.
3. Raad, I, Hachem, R, Hanna, H, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007;26:549556.
4. Wisplinghoff, H, Seifert, H, Wenzel, RP, Edmond, MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:11031110.
5. Planes, AM, Calleja, R, Bernet, A, et al. Evaluation of the usefulness of a quantitative blood culture in the diagnosis of catheter-related bloodstream infection: comparative analysis of two periods (2002 and 2012). Enferm Infecc Microbiol Clin 2016;34:484489.
6. Furuya, EY, Dick, AW, Herzig, CT, Pogorzelska-Maziarz, M, Larson, EL, Stone, PW. Central-line–associated bloodstream infection reduction and bundle compliance in intensive care units: a national study. Infect Control Hosp Epidemiol 2016;37:805810.
7. Chong, HY, Lai, NM, Apisarnthanarak, A, Chaiyakunapruk, N. Comparative efficacy of antimicrobial central venous catheters in reducing catheter-related bloodstream infections in adults: abridged cochrane systematic review and network meta-analysis. Clin Infect Dis 2017;64:S131S140.
8. Darouiche, RO, Berger, DH, Khardori, N, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 2005;242:193200.
9. Jamal, MA, Rosenblatt, JS, Hachem, RY, et al. Prevention of biofilm colonization by gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother 2014;58:11791182.
10. Chaftari, AM, Hachem, R, Szvalb, A, et al. Correction for Chaftari et al, “A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.” Antimicrob Agent Chemother 2017:61.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed